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Comprehensive list of SUMO 
targets in Caenorhabditis elegans 
and its implication for evolutionary 
conservation of SUMO signaling
Krzysztof Drabikowski1,2, Jacqueline Ferralli2, Michal Kistowski1, Jacek Oledzki1, Michal 
Dadlez1,3 & Ruth Chiquet-Ehrismann2,4
Post-translational modification by small ubiquitin-related modifier (SUMO) is a key regulator of cell 
physiology, modulating protein-protein and protein-DNA interactions. Recently, SUMO modifications 
were postulated to be involved in response to various stress stimuli. We aimed to identify the near 
complete set of proteins modified by SUMO and the dynamics of the modification in stress conditions 
in the higher eukaryote, Caenorhabditis elegans. We identified 874 proteins modified by SUMO in 
the worm. We have analyzed the SUMO modification in stress conditions including heat shock, DNA 
damage, arsenite induced cellular stress, ER and osmotic stress. In all these conditions the global 
levels of SUMOylation was significantly increased. These results show the evolutionary conservation of 
SUMO modifications in reaction to stress. Our analysis showed that SUMO targets are highly conserved 
throughout species. By comparing the SUMO targets among species, we approximated the total 
number of proteins modified in a given proteome to be at least 15–20%. We developed a web server 
designed for convenient prediction of potential SUMO modification based on experimental evidences in 
other species.
Small ubiquitin-related modifier (SUMO) proteins are covalently and reversibly coupled to intracellular protein 
targets, modulating protein-protein and protein-DNA interactions1. The post-translational protein modification 
by SUMO is achieved by similar mechanism as ubiquitination by a set of homologous but distinct enzymes2. The 
SUMO activation enzyme E1 (Aos1/Uba2 dimer) forms, in an ATP dependent manner, a thioester bond between 
its catalytical cysteine and the C-terminal carboxyl group of SUMO. Next, SUMO is transferred to the cysteine 
of the SUMO E2 conjugating enzyme, Ubc9. Finally, SUMO is transferred to the ε-group of lysine of the target 
protein, forming an isopeptide bond. This step is often achieved by the help of E3 SUMO ligase such as PIAS 
and RanBP23. The SUMO moiety is removed from the target proteins by SUMO isopeptidases from the SENP 
family4. Modification by SUMO regulates various aspects of cell physiology including cell cycle, DNA replication 
and repair, transcription, epigenetic gene silencing, intracellular trafficking and cell signaling5. Despite the vast 
implications of SUMO in various cellular processes, only few enzymes mediating SUMOylation are known. In 
comparison, the ubiquitin conjugation system involves almost thousand proteins. Recent work suggested that 
SUMOylation specificity comes from spatiotemporal determinants and thus, such a big number of proteins, as in 
case of ubiquitination, is not necessary6.
The variety and number of cellular processes regulated by the post-translational modification by SUMO is 
comparable to processes regulated by phosphorylation and ubiquitination. Several SUMO targets belong to path-
ways involved in cancer and neurodegenerative diseases7. For example, increased levels of UBC-9, the SUMO 
conjugating enzyme, result in tumor formation8. In several tumors the levels of the SUMO E3 ligase PIAS are 
elevated9. SUMO modification regulates the protein levels and activity of tumor suppressor proteins, for example 
p53, p63, p7310 and MDM211. Moreover, SUMO regulates the protein levels of huntingtin, amyloid precursor 
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protein, DJ-1, ataxin-1, tau and superoxide dismutase12. Thus, SUMO attachment to disease related proteins is 
discussed as a potential therapeutic target13.
Post-translation modification by SUMO was shown to be influenced under stress conditions. SUMOylation 
increases in response to heat shock in human cells14, Drosophila embryos15 and Arabidopsis16. Ischemia, the cold 
shock, also increases global levels of SUMOylation in neurons17. Furthermore, SUMOylation is increased in the 
re-oxidation phase of oxygen/glucose deprivation, a model for ischemia18. In yeast SUMOylation increases in 
response to DNA damage6. Protein modification by SUMO conjugation machinery was shown to be directly regu-
lated by the redox state of the cell19,20. Along the same lines, hydrogen peroxide treatment increased SUMOylation 
by SUMO2/3 but not via SUMO121. On the other hand, SUMOylation decreased upon ER stress in C. elegans22. 
Furthermore, SUMO isopeptidases have been shown to be inactivated by heat23.
Initially, research was focused on the functions of SUMO modification in the nucleus, for example chromatin 
remodeling, genome stability and RNA. Recently, involvement of SUMO in non-nuclear processes is emerging 
such as in protein folding, lipogenesis, autophagy24, membrane transport and proteostasis25. Research in C. ele-
gans revealed functions of SUMO in intermediate filament assembly26, ER stress22, chromosome assembly27 and 
assembly of adherens junctions to actin cytoskeleton28.
Recently, several whole proteome studies increased our knowledge about SUMO targets in human cells29–33. 
For recent compilation of SUMO targets in human cells please refer to a review by Henriks et al.33. However, 
SUMOylation is a very dynamic process which depends on the cell type, cell cycle stage and interactions of an 
organism with its environment. Thus, we investigated the targets of SUMO modification at the level of an entire 
organism, the nematode Caenorhabditis elegans. C. elegans is a complex higher eukaryote, but in contrast to ver-
tebrates, contains only one SUMO gene. This gene is essential and needs to confer all functions of SUMO modifi-
cations in a higher organism. Our study identified a comprehensive list of SUMO targets. Interestingly, we show 
that those targets are remarkably evolutionary conserved. Thus, we propose a novel bioinformatics approach to 
predict SUMO modification based on experimental data of other species.
Results
SUMO is expressed throughout life of C. elegans. In C. elegans only one gene is coding for SUMO, 
smo-1. Deletion of smo-1 is lethal. To analyze the posttranslational modification by SUMO in C. elegans, we gen-
erated a worm strain carrying a transgene composed of a N-terminally fused 8His-GFP to the worm SUMO gene 
(smo-1), called herein SUMO-GFP (Fig. 1A). The SUMO-GFP transgene rescues the lethal smo-1 gene deletion 
in the VC186 strain. The SUMO-GFP fusion was expressed in all cells, including germ cells where the transgenes 
are often silenced, and throughout all developmental stages (Fig. 1B). The SUMO-GFP protein is localized pre-
dominantly in the nucleus but the cytoplasmic expression is also detectable, especially in the gut cells (Fig. 2). In 
the nucleus the protein is localized into speckles (Fig. 2A, arrows) or label dividing chromosomes (Fig. 2A, star). 
In the cytoplasm of gut cells SUMO-GFP can be also detected in the apical membrane (arrow heads) and some 
vesicles (arrows) (Fig. 2D).
Modification by SUMO is increased under stress conditions. We analyzed the levels of SUMO 
modification applying various stress conditions to C. elegans. We studied the stress response throughout time 
after applying short, non-lethal stress and followed it until the level of SUMOylation reverted to steady state 
levels (Fig. 3, Fig. S1). SUMOylation was dramatically increased in response to heat shock (Fig. 3A), arsenite 
induced cellular damage (Fig. 3B), and UV induced DNA damage (Fig. 3C). Short osmotic stress (10 min 500 mM 
NaCl) induced also transient increase in SUMOylated proteins, albeit to a lower extent (Fig. 3F). Oxidative stress 
induced in the mitochondria by applying paraquat did not induce global increase in SUMOylation (Fig. 3D). 
Endoplasmic reticulum (ER) stress induced by tunicamycin initially increased SUMOylation to a small extend, 
followed by decreased SUMOylation (Fig. 3E). The period of elevated SUMOylation upon transient stress con-
dition varied depending on the stressor, from less than an hour in case of osmotic stress to over 6 hours in case 
of UV response. We confirmed the increase in SUMOylation in response to heat-shock in wild-type N2 worms 
using SUMO specific antibodies (Fig. S2).
Identification of SUMO targets in C. elegans. Our stress assays in worms showed increased amount 
of SUMO-conjugated proteins. Thus, we reasoned that the analysis of SUMO-conjugated proteins under stress 
conditions may yield to yet undiscovered SUMO protein targets in worms. Using the strain RU86 expressing 
HIS-GFP tagged SUMO we set up the purification of proteins modified by SUMO using immobilized metal ion 
affinity chromatography (IMAC). Control protein purifications and identifications from the wild-type N2 worms 
revealed several proteins bound to the IMAC column in a non SUMO-GFP specific manner (Table S1). Indeed, 
C. elegans proteome encodes over 500 histidine rich proteins. Thus, we analyzed in parallel proteins purified from 
SUMO-GFP tagged transgenic worms and N2 wild-type worms (Table S2). We applied single step IMAC purifi-
cation and compared the identified proteins with the wild-type control (Fig. S3A). Denaturing lysis conditions of 
boiling 1% SDS followed by SDS precipitation34 and single step purification using IMAC followed by comparison 
with proteins isolated from wild-type worms resulted in more specific target identification than purification in 
native condition, first by IMAC, followed by antibody purification. Lysis in boiling 1% SDS should abolish all 
protein-protein interactions and thus remove all SUMO or SUMO modified interacting proteins from the purifi-
cation. Example purification is presented in Fig. S3B. SUMO conjugates were identified by mass spectrometry and 
data were analyzed using MaxQuant (Fig. S3A). To consider a protein as being SUMOylated, the proteins had to 
be identified in at least 3 independent experiments, each protein identified with at least two peptides, FDR below 
1% and, not present in any of the control purifications from wild-type N2 worms or present with raw intensity 
greater than 10 times than in control purifications. The danger of this strategy is that some of the genuine targets 
that were accidently purified from control worms are excluded but we expected to identify very few falls positives.
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We applied our purification and identification approach to analyze SUMO conjugates in C. elegans under 
stress conditions. We analyzed the response upon treatment of worms when global changes in SUMOylation were 
the strongest, namely heat shock, arsenite treatment and UV irradiation (see also Fig. 3). For each condition a 
non-treated control population was analyzed. To exclude proteins that non-specifically were purified, we analyzed 
wild-type worms under steady state and heat shock conditions. Each described condition was repeated 3 times 
independently. Altogether, we have analyzed 31 independent purifications from worms carrying the transgene 
for the tagged SUMO protein and 6 independent purifications from wild-type N2 strain (3 from non-treated and 
3 from heat shock treated worms). Altogether, we have identified 874 proteins modified by SUMO in C. elegans in 
normal growth conditions and upon stress (Table S2). Unfortunately, variability of biological replicates prevented 
us from quantifying the differences between stress conditions in a statistically significant manner (Figs S4 and 
S5). Therefore, we analyzed only qualitative changes of presence/absence of an identified protein in a particular 
condition (Table S3). For a protein to be included in the difference list, it had to be identified in at least 2 out of 
3 replicates in one condition and in none of the compared condition. Relatively low number of differentially 
Figure 1. SUMO is expressed throughout development and in all cells in C. elegans. (A) Schema of translational 
fusion of HIS-tagged GFP with smo-1 gene under the control of the endogenous smo-1 promoter and including 
the endogenous 3′-UTR. (B) Fluorescent images of different developmental stages (L1, L2, L3, dauer, L4, adult 
hermaphrodite, adult male) of C. elegans stably expressing HIS-tagged GFP::smo-1 construct in RU86. Anterior 
is to the left, ventral is to the bottom. Scale bar 100 µm.
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identified proteins suggests that targets of SUMOylation in normal and stress conditions are similar but the level 
of modification in stress conditions is highly increased. Furthermore, proteins found to be modified in normal 
conditions or shortly after stress (30 min) are often not modified 120 min after stress.
To validate our mass spectrometry data we used several antibodies to detect specific SUMO conjugated pro-
teins. We confirmed SUMOylation of actin, alpha tubulin, mannosidase II, GRP94, catalase and cytochrome c1 
which have been previously identified as SUMO targets in human cells (Figs 4 and S6).
Our study showed only a 25% (63 common, 810 specific this work, 185 specific for previously published tar-
gets26) overlap of SUMO conjugated proteins with the only present work on SUMO targets in C. elegans26. Thus, 
we conclude that the number of identified SUMO target proteins in worms is not saturated yet. Applying different 
purification strategies can yield in jet more comprehensive list of SUMO modified proteins in C. elegans.
Functional analysis of SUMOylated proteins in C. elegans. In our study we identified 874 proteins 
modified by SUMO in C. elegans. Gene ontology analysis showed that we identified proteins involved in early 
development and reproduction (Fig. S7C). The regulation of proteins during C. elegans development is in agree-
ment with our data on the ubiquitous expression of SUMO in worms, especially high in developing embryo. 
Further, we identified nuclear proteins involved in genome stability, cell cycle progression, chromatin mainte-
nance and modification, RNA splicing and ribosome biogenesis (Fig. 5A). Albeit, most of SUMOylation in the 
RU86 strain took place in the nucleus, the vast majority of the identified proteins were non-nuclear. Surprisingly, 
to a large extend these proteins are mitochondrial or extracellular (Figs 5B and S7A). None of the mitochondrial 
proteins identified was mitochondrially encoded though, suggesting involvement of SUMO in the biogenesis of 
mitochondrial proteins prior their translocation into the organelle.
Cytosolic proteins undergoing SUMOylation included proteasomal and ribosomal proteins; also proteins 
involved in metabolism, signaling, cell morphology and motility (cytoskeleton, microtubules, intermediate fila-
ments and proteins involved in connecting cytoskeleton to the plasma membrane). Several membrane transport 
Figure 2. SUMO expression is enriched in the nucleus. (A–D) Stacked confocal images of subcellular 
localization of HIS-tagged GFP::smo-1 in RU86. (A) 6-cell stage embryo. Arrow, nuclear speckles. Star, mitotic 
chromosomes (B) Embryo at gastrulation stage. (C) Comma stage embryo. (D) Zoom in into adult worm 
showing expression in the intestine and (upper part of image) and germline (lower part of image). Arrow, 
vesicles. Arrowhead, apical membrane. Scale bar 10 µm.
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and vesicular transport proteins were also found to be modified by SUMO. Moreover, proteins involved in stress 
response, ROS homeostasis and proteostasis were regulated by SUMOylation (Figs 5A and S7).
In previous studies, proteins found to be modified by SUMO were highly interconnected30. We tested the 
interconnectedness of the identified SUMO targets in our study using the STRING database35. Indeed, the iden-
tified C. elegans proteins modified by SUMO are highly interconnected (Fig. 6A). The most prominent clusters 
included the proteasome, ribosome biogenesis and redox regulation (Fig. 6B). Such robust modification of pro-
teasomal proteins was previously unidentified. Close inspection of proteasomal proteins modified by SUMO 
Figure 3. SUMO conjugation to target proteins response to stress conditions. (A–F) Mixed stage worms of 
RU86 strain were exposed to stress conditions: (A) heat shock, (B) Na3As03, (C) ultraviolet light, (D) paraquat, 
(E) tunicamycin and (F) 0.5 M NaCl. Worms were harvested at indicated time points after exposure to the 
stress. Control, non-treated worms indicated by -.Total protein lysate of worms was separated by SDS-page and 
immunodecorated with anti-GFP antibody.
Figure 4. Validation of actin and alpha-tubulin as SUMO targets. Total worm lysate and elution of the 
purification of GFP-tagged SUMO was analysed by western blot and decorated with specific antibodies.
www.nature.com/scientificreports/
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showed that most of proteins forming the core subunit as well as proteins from the base and the lid were SUMO 
conjugated.
In summary, we identified the largest number of SUMOylated proteins in C. elegans up to now including 
previously unnoticed classes of potential SUMO targets such as proteasomal proteins as well as mitochondrial 
and secreted ones.
Conservation of SUMO target proteins. To address the question of conservation of SUMO target pro-
teins and relevancy of research on SUMO in C. elegans we analyzed how evolutionary conserved are the SUMO 
targets in the worm in comparison to the overall protein conservation between species. We compared the list of 
SUMO modified proteins in the worm to the yeast36, Drosophila37, Xenopus38, Arabidopsis39, human33 and mouse40 
proteomes using a strict definition of an ortholog requiring BLASTP e-value below 10−10 along at least 80% length 
of the proteins (Table 1). Applying these strict conditions, approximately 65% of SUMO targets in C. elegans have 
homologues in human proteome. This represents high enrichment compared to approximately 8% of homology 
of entire proteomes using the same conditions of comparison.
Since C. elegans carry only one SUMO gene and vertebrates 4, we asked if worm SUMO targets are more con-
served with human SUMO1 or SUMO2/3 targets. We found that in humans, homologues of worm SUMO targets 
are modified both by SUMO1 and SUMO2/3 with no statistical significant bias.
SUMO target predication by extrapolation from other species. Our and others’30 analyses showed 
remarkable evolutionary conservation of SUMO targets throughout species. We assumed that if SUMO targets are 
so evolutionary conserved and the processes they are involved are also conserved, regulation of this proteins by 
SUMOylation might also be conserved. Thus, we attempted to predict occurrence of SUMO modification based 
on the experimental knowledge about the modification in any of the previously analyzed species. We applied 
a strict definition of an ortholog requiring BLASTP e-value below 10−10 along at least 80% length of the pro-
teins. This extrapolation predicts the number of SUMOylated proteins in C. elegans to be approximately 4735, in 
humans 11115, in mouse 11777, in A. thaliana 5663, in X. laevis 6579, in D. melanogaster 2051 and in S. cerevisiae 
1436 (Table S4). Our prediction suggests that at least 15–20% of the eukaryotic proteome can be modified by 
SUMO.
Figure 5. SUMO modifies targets involved in a broad range of cellular processes in the nucleus, cytosol and at 
membranes in C. elegans. (A) Grouping of identified SUMO targets in broad functional classes. (B) Grouping of 
identified SUMO targets based on cellular localization.
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We tested our prediction by analyzing the human proteins that we have predicted to be SUMOylated but were 
not identified in the published experimental identifications. We have analyzed if these proteins carry any of the 
SUMO consensuses described by Hendriks et al.30. 88% of proteins predicted carried the consensus site compared 
to 94% of the experimentally identified ones. In contrast, in the entire human proteome, 65% of proteins carry the 
consensus site and 60.5% in the part of the proteome not shown or predicted to be SUMOylated (Table 2). The 
p-value of this enrichment is below 2.2 × 10−16.
Figure 6. SUMO modifies highly interconnected networks of proteins in C. elegans. (A) Entire network of 
identified proteins analyzed by STRING database and visualized by Cytoscape. Clusters were labeled with 
different colors (B). Individual, most prominent clusters are shown. MCODE score is in parentheses.
www.nature.com/scientificreports/
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SUMO target predication web server. To facilitate access to predictions of SUMO modifications based 
on evolutionary conservation of known targets, we have established a publicly available web server (sumobase.
mslab-ibb.pl). Sequence alignments of known and predicted SUMOylated proteins is shown is Fig. S8B. The data-
base contains known and predicted SUMO targets in C. elegans, H. sapiens, M. musculus, X. laevis S. cerevisiae, D. 
melanogaster and A. thaliana. Screenshots of the web page are presented in Fig. S8.
Discussion
Every dynamic protein modification depends on the developmental stage, cell type and cell cycle stage. Analysis 
on the level of the entire organism enables a search throughout the entire spectrum of targets and modifications. 
Caenorhabditis elegans is an excellent model to decipher the universe of the proteins and processes regulated by 
SUMO. C. elegans enables identification of targets in all tissues and developmental stages. Recent high through-
put proteomics identifications from human cells (for review see Hendriks and Vertegaal33) could not decipher 
the SUMO proteome in embryonic development and many tissues, for example neurons, germline, and liver or 
kidney cells.
We have analyzed SUMO modifications in C. elegans in all developmental stages and in various stress condi-
tions: heat shock, DNA damage, ER stress, osmotic stress and complex inhibition of many enzymes and pathways 
by arsenite. Other studies have shown that SUMOylation is increased in ischemia17,41 and drought in plants42. 
All these stressors elicit different defense responses; nevertheless all result in increased levels of SUMOylation 
suggesting that SUMO is a key stress response protein on which many stress resistance mechanisms converge.
We have identified 874 proteins modified by SUMO in C. elegans, more than 3 times more than previously 
reported26. We compared the list of proteins identified in this study with the previously published data in C. 
elegans26. Surprisingly, there is little overlap between the set of proteins identified by Kaminsky et al. This might 
be due to a completely different purification strategy. We found that two step purification in native conditions, 
using IMAC followed by antibody purification resulted in much false positive identification of proteins that were 
purified from wild-type N2 worms. This is, probably due to high number of poly-His and carbohydrate binding 
proteins in worms as well as co-purification of SUMO interacting proteins and proteins interacting with SUMO 
targets. In contrast, our strategy of lysing worms in boiling 1% SDS should exclude all SUMO interacting proteins 
as well as proteins interacting with SUMO modified proteins.
We identified several known targets of SUMOylation for example proteins involved in cell cycle regulation, 
transcription, translation and cytoskeleton confirming the conservation of these processes being regulated by 
SUMO. We have identified several new targets of SUMO modification related to cell homeostasis and metabo-
lism. Metabolic processes have been shown to be regulated by SUMOylation of transcription factors governing 
expression of metabolic enzymes43. In previous proteomics studies, proteins involved in metabolism and homeo-
stasis were also identified but at much smaller proportion than in our study. Our analysis suggests also that other 
cellular processes are regulated by SUMOylation. Beside the ribosome, the other macromolecular complexes 
heavily modified by SUMO were the proteasome and proteins involved in maintenance of cell shape and motility.
Species Proteome
Homologues in C. 
elegans proteome
Homologues in C. 
elegans SUMO targets
Enrichment 
p-value
C. elegans 26723
H. sapiens 72874 6010 570 >2.2 × 10−16
M. musculus 50311 5977 580 >2.2 × 10−16
X. laevis 16378 4939 503 >2.2 × 10−16
D. melanogaster 21977 5066 529 >2.2 × 10−16
A. thaliana 31392 2993 393 >2.2 × 10−16
S. cerevisiae 6838 1886 275 >2.2 × 10−16
Table 1. Evolutionary conservation of C. elegans SUMO targets with other species. C. elegans proteome and 
SUMO targets from C. elegans were compared to whole proteomes and to orthologues of C. elegans proteins in 
other species. Only strict homologues with BLASTP e-value smaller than 1 × 10−10 and over 80% of residues in 
both sequences included in the BLASTP alignment, were included in the comparison.
Sequences
[IV]
KE
[VF]K[QTEP]
[ED][PKE] KE[ED]5 [ED]K
All 
motifs
Containing 
SUMOylation motif
Identified SUMO targets 4146 1343 293 41 3862 3905 94.19%
Predicted SUMO targets 7161 1348 234 24 6219 6298 87.95%
Proteome 70956 8184 1300 148 45462 46286 65.23%
Proteome minus 
(identified + predicted) 59649 5493 773 83 35381 36083 60.49%
Table 2. Testing of SUMOylation prediction by analysis of SUMO motifs in predicted human proteins. 
Percentage of human proteins predicted in this study but not previously experimentally identified, carrying 
experimentally defined SUMOylation consensus; compared to the presence of consensus in identified proteins, 
the entire human proteome and the proteome lacking identified and predicted SUMO targets. The p-value of 
the enrichment is below 2.2 × 10−10.
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In this study, we have identified several mitochondrial proteins as well as extracellular proteins. It is surprising 
because SUMOylation is a strictly nuclear and cytosolic process. However, recently it was shown that several 
inner mitochondrial proteins undergo ubiquitin mediated proteasomal degradation44. Furthermore, proteins can 
be exported from the mitochondrion for proteasomal degradation45. SUMO tagging is also known to indirectly 
target protein for proteasomal degradation46. Moreover, it was shown that accumulation of newly synthetized, 
misfolded proteins triggers SUMO conjugation response47. Thus, we propose that misfolded mitochondrial and 
secreted proteins are first SUMOylated, subsequently polyubiquitinated and degraded by the proteasome.
C. elegans SUMO does not contain SUMOylation consensus site. Yeast SUMO (Smt3) and human SUMO2/3 
can form poly SUMO chains. Sequence analysis suggests that C. elegans SUMO is not more similar to SMT3 or 
to human SUMO2/3 than to human SUMO1 (Fig. S9). However, our functional analysis of identified SUMO 
targets, i.e. in response to stress suggests that worm SUMO can be functional related to SUMO2/3. The presence 
of high molecular weight SUMO-conjugates on the immunoblot might suggest that SUMO protein forms chains 
in C. elegans and thus, can be a signal for polyubiquitination and subsequent proteasomal degradation. C. elegans 
Y47G6A.31 protein show weak homology to S. pombe Rfp1 and human RNF4 proteins responsible for SUMO 
chain directed polyubiquitiantion. Another argument for C. elegans SUMO being a functional homologue of 
SUMO2/3 is that SUMO2/3, in contrast to SUMO1, in normal conditions is present as a pool of free protein 
and is being attached to target proteins upon stress48 what is also true in case of the worm SUMO protein. Thus, 
it is reasonable to assume that the only C. elegans SUMO performs all functions reserved for both SUMO1 and 
SUMO2/3 in vertebrates.
SUMOylation is a very dynamic process depending on developmental state of an organism as well as internal 
and external state of the cells. Precise mass spectrometry identification of SUMO modified proteins in verte-
brates would require isolating and identifying SUMO conjugates from all cells and tissues in all developmental 
stages of a mouse, for example. Knowledge of close to complete list of SUMO targets is essential if SUMO path-
way is to become a target of therapeutic interventions in humans. Thus, several groups attempted to predict 
potential SUMOylation based on the presence of SUMO modification consensus sites and other sequence fea-
tures49,50. These attempts are usually hampered by the fact that 65% of proteins in the human proteome carry the 
SUMOylation consensus. In recent years almost 4000 human proteins have been experimentally identified to be 
SUMOylated. A major limitation of these identifications is that SUMO conjugates are isolated from few cell lines. 
Thus, our approach to identify SUMO modified proteins at the level of entire higher eukaryotic organism, at all 
stages of development; combined with prediction based on evolutionary conservation of targets is a useful step 
towards deciphering the entire SUMOylonome.
We predict that at least 15–20% of the eukaryotic proteome can be SUMOylated and suggest that SUMO func-
tions in 3 main areas: regulation of activity of individual proteins, biogenesis of macromolecular complexes and 
SUMO directed proteasomal degradation.
Methods
C. elegans and bacterial strains. Worms were maintained and handled in standard conditions as 
described by Brenner51. Worms were cultured at 20 °C unless stated otherwise on plates seeded with E. coli HB101 
bacteria. Strains used in this study: N2 (wild type) and VC186[smo-1(ok359)/szT1 [lon-2(e678)] I; +/szT1 X] 
(provided by the Caenorhabditis Genetics Center), RU86[smo-1(ok359); Is(psmo-1::smo-1gfp::3′UTRsmo-1].
Constructs and transformation. The 8-HisGFP tagged SUMO was constructed as follows: The 
SUMO coding sequence and 3′UTR was amplified from the worm genomic DNA with the primers 5′ 
ACTCCCGGCTAGCACGATGGCCGATATGC and 3′ GGACGGAGAAGGCCTTCGAATCTCGTGTC and 
cloned into NheI and StuI sites of the pPD117.01 vector. The 8-His tag was introduced into pPD117.01 vector 
(Fire kit) by PCR together with the SUMO promoter. The SUMO promoter (1 kb) was amplified from 
the genomic DNA with 5′-ATTTTATCACGGGCATGCTGGCCTTCCTC, 3′-CATGCTACCACACC 
ATCACCATCACCATGCCGATGATGCAGCTCAAATTC primers and cloned into SphI and KpnI siteS of the 
pPD117.01 vector (Fire). The 3′ primer introduced 8His tag at the N-terminus of the GFP.
VC186 SUMO knock-out strain was transformed by biolistic transformation as previously descried52. 
Integrated transformers were selected by repeated sorting of GFP positive animals with the COPAS worm sorter 
(Union Biometrica) for 40 generations. Integrated strain was back-crossed 10 times with wild type N2 worms.
Sumo conjugate purification. SUMO conjugates were purified under SDS denaturing condition as 
described34,53. Briefly, worms were grinded in liquid nitrogen and resuspended in boiling SDS lysis buffer (25 mM 
NaPO4 pH 7.5, 300 mM NaCl, 1%SDS) and sonicated at 20% for 2 min with Branson sonifier (Branson). Next, 
the lysate was spun down for 30′ at 20000 g at 4 °C. Supernatant was transferred to new tubes and cooled on ice 
for at least 30′ to precipitate the SDS. The lysate was cleared of precipitated SDS by centrifugation at 10000 g for 
30′ at 0 °C. The cleared lysate was filtered through 0.22 μ filter and applied to IMAC column (GE Healthcare) 
equilibrated with the buffer (25 mM NaPO4 pH 7.5, 300 mM NaCl, 20 mM imidazole. 0.1% sarcosyl). The column 
was washed with at least 20 volumes of the wash buffer (25 mM NaPO4 pH 7.5, 300 mM NaCl, 50 mM imidazole. 
0.1% sarcosyl). Proteins were eluted with 2 column volumes of the elution buffer (25 mM NaPO4 pH 7.5, 300 mM 
NaCl, 300 mM imidazole. 0.1% sarcosyl).
In-solution digestion by FASP. Isolated proteins were prepared for mass spectrometry analysis by FASP 
(Filter Assisted Sample Preparation)54. Briefly, 50 μg of each sample was reduced with 50 mM DTT at 55 °C for 
30 min, diluted 1:8 in 8 M urea and applied to Vivacon 500 ultrafiltration unit MWCO 30000 (Sartorius). Samples 
were washed twice with 8 M urea, free cysteins were blocked with 50 μM iodoacetamide in 8 M urea and the filters 
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were washed twice with 8 M urea and twice with 50 mM NH4HCO3. Next, the samples were digested in a wet 
chamber, O/N with trypsin (Promega) in 50 mM NH4HCO3, protein: trypsin ratio 100:1.
Mass spectrometry. Peptide mixtures were applied to RP-18 precolumns (nanoACQUITY Symmetry® 
C18—Waters) using water containing 0.1% trifluoroacetic acid as mobile phase and then transferred to 
nano-HPLC RP-18 columns (nanoACQUITY BEH C18—Waters) using an acetonitrile gradient (5–35%) for 
180 min in the presence of 0.05% formic acid with a flow rate of 250 nl min−1. The column outlet was directly 
coupled to the ion source of Q Exactive™ Hybrid Quadrupole-Orbitrap Mass Spectrometer (Thermo Electron 
Corp). The mass spectrometer was operated in positive ion mode with a selected mass range of 300–2000 mass/
charge (m/z).
Data processing analysis. Raw files were processed, including peak list generation, using the MaxQuant 
(v1.5.7.4) computational proteomics platform and default parameters were used. The fragmentation spec-
tra were searched using Andromeda search engine integrated into the MaxQuant platform against a custom, 
non-redundant database of C. elegans proteome that included the sequence of the SUMO-GFP protein. The 
error ranges for the first and main searches were 20 ppm and 6 ppm, respectively, with 2 missed cleavages. 
Carbamidomethylation of cysteines was set as a fixed modification, and oxidation and protein N-terminal acetyl-
ation were selected as variable modifications for database searching. The minimum peptide length was set at 6 
aa. Both peptide and protein identifications were filtered at a 1% false discovery rate. Enzyme specificity was set 
to trypsin.
The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the 
PRIDE55 partner repository with the dataset identifier PXD006644.
Stress assays in C. elegans. Heat shock was induced by 15′ incubation in at 33 °C in a water bath. UV stress 
was induced by irradiation of 100 J/m2 UV 254 nm in a Stratalinker (Stratagene). Arsenite treatment 30′ 5 μM 
sodium arsenite (Sigma) in M9. Osmotic stress was induced by incubation in 500 mM NaCl in M9 for 10′. ER 
stress was introduced by 30′ incubation in 5 μM tunicamycin in M9. Oxidative stress was introduced by 30 min 
incubation in 10 μM paraquat in M9.
Microscopy. Worms were anesthetized in 20 mM sodium azide in M9 and immobilized on 2% agarose pads. 
Fluorescent images were taken with Zeiss Observer D1 microscope 40 × 0.6 lens, excitation 480 nm LED light 
source, Confocal images were takes with Olympus FV1000 microscope (Olympus) 60 × 1.4 oil immersion lens. 
Excititation 440 nm. The images were processed with ImageJ v 1.51n.
Immunoblot analysis. Worms were collected at different time points in M9 buffer, spun down and equal 
volume 2x SDS lysis buffer (50 mM NaPO4 pH 7.5, 600 mM NaCl, 2%SDS) was added. Worms were frozen in 
liquid nitrogen, thawed and sonicated at 10% for 2 min with Branson sonifier (Branson). The lysates were spun 
down. The protein content was measured with BCA kit (Thermo Scientific). 20 μg of protein lysate was loaded 
on each lane and separated by SDS-PAGE followed by electroblotting on PVDF membrane. The membrane was 
blocked with 5% non-fat milk and incubated with anti-GFP antibodies (Roche) o/n followed by horse radish con-
jugated secondary antibody. Rabbit antibody against C. elegans SUMO was generated against the N-terminal pep-
tide MADDAAQAGDNAEYIKIK (Eurogentec). Antibodies used to confirm the SUMO modification included: 
anti actin (MAB1501 from Chemicon), anti alpha tubulin clone DM1A (Sigma T9026), anti mannosidase II 
(AbDSerotec AHP674), anti cytochrome C1 (custom made), anti catalase (SantaCruz sc-365738) anti GRP94 
(SantaCruz sc-11402). The secondary antibody was detected with ECL system.
Bioinformatics analysis. Network analysis was performed using STRING database56, minimal interactions 
score was set to “high confidence”. STRING generated networks were further analyzed by Cytoscape57.
Proteins were considered as orthologues when the BLASTP E-value was smaller than 1 × 10−10 and over 80% 
of residues in both sequences included in the BLASTP alignment58. Enrichment analysis p-value was calculated 
using Pearson’s Chi-squared test with Yates’ continuity correction. The multiple sequence alignment was per-
formed by MUSCLE software59.
Evolutionary analyses were conducted in MEGA760. The evolutionary history was inferred by using the 
Maximum Likelihood method based on the Whelan And Goldman model.
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